TFB Advisors LLC grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 6.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 626 shares of the semiconductor company’s stock after purchasing an additional 37 shares during the quarter. TFB Advisors LLC’s holdings in Synopsys were worth $268,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in SNPS. Brighton Jones LLC lifted its stake in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares during the period. XTX Topco Ltd purchased a new position in shares of Synopsys in the 4th quarter worth $228,000. Jump Financial LLC purchased a new position in shares of Synopsys in the 4th quarter worth $453,000. NewEdge Advisors LLC raised its position in shares of Synopsys by 5.1% in the 4th quarter. NewEdge Advisors LLC now owns 2,615 shares of the semiconductor company’s stock worth $1,269,000 after buying an additional 127 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Synopsys by 516.0% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 154 shares of the semiconductor company’s stock worth $75,000 after buying an additional 129 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 1.9%
NASDAQ:SNPS opened at $601.13 on Thursday. The company has a market capitalization of $93.27 billion, a price-to-earnings ratio of 43.40, a price-to-earnings-growth ratio of 4.06 and a beta of 1.15. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a 50-day simple moving average of $565.67 and a 200 day simple moving average of $499.85. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02.
Insider Buying and Selling at Synopsys
In related news, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares of the company’s stock, valued at $7,427,144.52. This trade represents a 32.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares in the company, valued at approximately $699,746.85. This trade represents a 85.85% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock worth $13,001,048 over the last ninety days. Company insiders own 0.62% of the company’s stock.
Wall Street Analyst Weigh In
SNPS has been the topic of several research reports. Needham & Company LLC reissued a “buy” rating and issued a $660.00 price objective (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Piper Sandler raised their price objective on Synopsys from $615.00 to $660.00 and gave the company an “overweight” rating in a research report on Monday, July 21st. Bank of America raised their price objective on Synopsys from $575.00 to $625.00 and gave the company a “buy” rating in a research report on Wednesday, July 16th. Stifel Nicolaus set a $550.00 target price on Synopsys in a research note on Monday, April 28th. Finally, Morgan Stanley restated an “overweight” rating and set a $715.00 target price (up from $540.00) on shares of Synopsys in a research note on Monday, August 11th. Thirteen equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and a consensus target price of $630.67.
Check Out Our Latest Stock Analysis on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Best Stocks Under $5.00
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- Technology Stocks Explained: Here’s What to Know About Tech
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.